The two cell lines also expressed Krt19, a marker typically associated with cholangiocarcinoma, which is a recognized finding in highly aggressive HCCs with poor prognosis (Govaere et al., 2014). This evidence concerns the gene KRT19 and cholangiocarcinoma.